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ABSTRACT 
 
The Impact of Lipid Percentage on Fibrous Cap Stability in Atherosclerotic 
Lesions 
Anita Lorraine Crompton 
 
Coronary artery disease (CAD) is a common cause of sudden cardiac death.  
Much of the disease is not completely understood, which makes treatment 
and prevention difficult.  Many researchers are using technology, such as 
advanced imaging techniques and finite element analysis, to better 
understand the disease.  While there is much progress being made to look at 
the analysis of actual excised diseased arteries, there is still not a 
standardized model to predict the future of any one lesion.  The purpose of 
this study is to explore the possibility of creating a standardized model to 
predict the mechanical stability of the fibrous cap due to lipid content in 
atherosclerotic lesions. 
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INTRODUCTION 
 
Coronary artery disease (CAD) is the leading cause of death in United States.  
CAD is simply described as the lack of oxygen transport to the myocardium 
due to the inefficiency of the coronary artery to correctly transport blood.  
Because the heart is a vital muscle to the transport oxygen, nutrients, and 
waste throughout the body, coronary artery disease can often be fatal.  Many 
efforts have been made to prevent deaths due to this disease; however there 
are still much needed improvements on current treatment and preventative 
methods.  Atherosclerosis can cause CAD when plaque builds up in the 
lumen of arteries that provide blood to the heart.  Eventually, this buildup can 
significantly (or completely) close the lumen and disrupt efficient blood flow.  It 
can also fissure or rupture, causing the formation of a thrombus that can 
eventually get caught elsewhere in the vascular system. 
 
When the heart muscle is not receiving enough blood, angina pectoris can 
occur, which causes chest pain, but is not immediately fatal to the myocardial 
cells.  If the myocardial cells do not receive enough blood for long periods of 
time, they can die, causing a myocardial infarction.  This is a very serious 
complication of CAD as it is often fatal.   
 
In order to prevent myocardial infarctions doctors may choose from either 
minimally invasive clinical treatments, such as angioplasty or stents, or more 
 2 
invasive open-chest surgery.  In severe cases, bypass surgery can be 
performed, where the surgeon takes a part of the patient’s saphenous vein 
and “re-routes” the bloodstream past the blockage.  Although bypass surgery 
is usually successful, there may be limitations on the availability of a healthy 
saphenous vein due to a limited supply and other possible diseases.  While 
synthetic grafts are used in some areas of the body, they are not able to be 
used for coronary arteries due to their small diameter.  If disease behavior 
and biomechanics could be better understood, dangerous disease states 
could be detected early and accurately.  With this knowledge, doctors would 
be able to provide safer and more effective treatment. 
 
Although clinical knowledge of atherosclerosis has rapidly increased over the 
last couple of decades, it is still very difficult to predict its progression in a 
specific patient.  Research in vascular physiology and physical and numerical 
modeling may one day allow for significantly more effective disease detection 
and treatment.  This paper discusses the progression of atherosclerosis, the 
mechanical properties of the tissues involved, and the vulnerable states of the 
disease.  A finite element method is then used to test the vulnerability of 
different lesion morphologies, followed by a discussion of how the model can 
be applied clinically. 
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CHAPTER ONE:  ATHEROSCLEROSIS PROGRESSION AND 
CLASSIFICATION 
 
Atherosclerosis is a disease that affects the tunica intima (the innermost 
layer) of arteries.  Unfortunately, much about the physiologic initiation and 
progression of the disease is still not understood.  Many theories have 
evolved over time, and today it is agreed upon that inflammation plays a 
major role. 
 
NORMAL ARTERY ANATOMY AND PHYSIOLOGY 
 
 The cardiovascular system is extremely important to the human body, as the 
circulation of blood to every cell in the body is necessary for survival.  Since 
oxygen can only diffuse freely 200µm, the vascular system must be able to 
pump blood to every cubic centimeter of the body.  In addition to the large 
amount of capillaries necessary to reach every cell, the heart must be efficient 
enough to pump blood through the entire arterial system. In order for the 
heart to be efficient, is necessary for the vascular system to also deliver 
oxygen-rich blood to the myocardial cells.   
 
This system is composed of many arteries and veins that allow blood to flow 
between the heart, lungs, and other tissues in the body.  Arteries are the 
vessels responsible for delivering blood from the heart to all the tissues in the 
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body; therefore, normal function is of great importance.  Arteries are 
composed of three concentric layers, or tunics: the intima, media, and 
adventitia.  The intima is the innermost layer and makes up the lumen of the 
vessel.  It contains a monolayer of endothelial cells that continue from the 
endocardium of the heart.  Because it is in direct contact with flowing blood, 
the endothelium provides a low friction interface that discourages platelets 
from coagulating. The middle layer, or media, is the thickest layer in these 
arteries and contains smooth muscle cells and elastin that control vasodilation 
and vasoconstriction. These cells are what give the vessel most of its tensile 
strength.  The outer layer, called the adventitia, surrounds the vessel and 
contains collagen fibers which aid in protection and reinforcement.  A normal 
artery can be seen in Figure 1. 
 
 
Figure 1.  THE NORMAL ARTERY  A healthy artery consists of three tunics: the intima, 
media and adventitia.  The intima contains the endothelial lining, which has non-
thrombogenic properties and is in direct contact with the blood. 
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PROGRESSION OF ATHEROSCLEROSIS 
 
The development of a clinically significant atherosclerotic lesion typically 
takes decades, and there are many types of lesions and factors involved in 
disease progression.  Plaque buildup due to atherosclerosis is thought to be 
an inflammatory response that builds up smooth muscle cells, calcium, and 
other products over time.   
The initiation of a lesion is due to the adhesion of mononuclear leukocytes to 
the endothelium.  The exact reason for this is unknown, but it is believed that 
a disruption in the endothelial lining, possibly due to normal blood flow or 
infection, may cause this inflammatory response.  However, there is also 
speculation that the adhesion of leukocytes can happen without endothelial 
disruption, so the subject still remains somewhat controversial.   After 
adhering to the endothelial lining, the leukocytes are drawn into the intima by 
chemoattractants.  This causes a local inflammatory response, and the 
leukocytes become macrophages.  The macrophages then engulf lipids and 
become foam cells.  This phagocytosis can happen when low density 
lipoproteins from the blood plasma become oxidized and bind to the 
macrophages.  An accumulation of these foam cells is typically referred to as 
a fatty streak, which is the initial precursor to the progression of advanced 
atherosclerosis.  Fatty streaks are present in the first decades of life, and 
some research even shows that initial fatty streaks can be present upon birth.  
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It is possible for a disease state consisting of fatty streaks to completely 
reverse, so is not considered clinically dangerous.  As the disease 
progresses, lipoproteins accumulate beneath the endothelial lining.  This may 
happen after the lipoproteins are released by necrotic subendothelial foam 
cells.  The exact reason for the death of foam cells is unknown, but it may be 
due to signals that cause the cells to undergo apoptosis.  An accumulation of 
lipoproteins underneath the endothelial lining is termed atheroma. 
 
As time and accumulation of foam cells progresses, growth factors are 
released that encourage the growth of smooth muscle cells and fibrous 
tissue.  The smooth muscle cells produce an extracellular matrix which 
contributes to the fibrous properties of a more advanced lesion.  Collagen and 
smooth muscle cells grow around the atheromatous core to help prevent its 
clotting factors from coming into contact with the bloodstream, and a fibrous 
cap develops.  This is often thought to help stabilize the lesion, but is also a 
controversial issue.  A lesions containing an atheromatous core surrounded 
by a fibrous cap is a fibroatheroma.  A fibroatheroma may have multiple lipid 
pools surrounded by fibrous tissue.  The thickness and mechanical properties 
of the fibrous tissue varies greatly between lesions and is largely dependent 
on biological factors. 
 
Some lesions develop calcific regions, which can be located anywhere within 
the lesion, but are usually closer to the media.  The exact mechanism of this 
 7 
calcification is unknown, but some researchers hypothesize that it may be 
due to the mineralization of vesicles from dead cells.  Another speculation is 
that smooth muscle cells produce proteins that promote bone formation and 
mineralization. 
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Figure 2.  ARTERY WITH CALCIFIC REGIONS  MRI and histological image from a study 
done by Tang et al.  (a) MR image (b) histological image 44 
 
 
Figure 2 shows a histological image and its corresponding MRI of an 
atherosclerotic lesion containing an atheroma, fibrous cap, calcium.  The 
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morphology of each lesion varies greatly between each person, and can even 
vary between arteries in the same person.  Efforts are currently being made 
to discuss methods of classifying these morphologies so that clinicians can 
better choose the proper treatment for their patients. 
 
 
CLINICAL IMPLICATIONS 
 
An atherosclerotic lesion becomes clinically relevant when it causes stenosis 
of the lumen, or becomes likely to rupture or cause a thrombus.   A severely 
stenosed lumen can be debilitating, especially when it is in the coronary 
arteries and causes angina pectoris.  If the fibrous cap ruptures, a thrombus 
will most likely form when blood is exposed to clotting factors below the 
endothelial surface.  The thrombus may occlude the artery at the lesion site, 
or break loose, get caught and inhibit blood flow elsewhere. 
 
There are many possible causes for plaque rupture.  One possible cause is 
stress on the intimal lining due to normal physiologic stresses, such as blood 
flow.  The constant pulsatile flow of blood causes fatigue and weakens the 
fibrous cap over time.  High blood pressure can impose a greater than normal 
stress, and thus is a risk factor for plaque disruption.  Hemodynamic (shear) 
stresses usually do not facilitate plaque rupture since the mechanical stresses 
due to the pulsatile flow of blood exceed any stresses related to the 
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circulation of blood.  Other triggers may be internal; for instance, newly 
formed thin walled blood vessels inside the plaque may bleed into the lesion 
and cause internal pressures on the fibrous cap. 
 
Lesions which are prone to rupture include those with large lipid pools, thin 
fibrous caps, and caps with low collagen content.  Large atheromatous cores 
are typically classified as those in which the lipid pool occupies 40% or more 
of the plaque.  Since the lipid core is softer than the fibrous cap, it does not 
absorb nearly as much stress.  This extra stress on the fibrous cap can cause 
it to rupture.  The size of the fibrous cap varies greatly between lesions, as 
does the thickness required to consider a cap stable.  For instance, the range 
of cap thickness of stable coronary lesions can range from 65 µm to 250 µm, 
depending on the mechanical properties of the fibrous tissue of the cap.  
Caps that have higher collagen content and more smooth muscle cells, which 
make collagen, are more stable because they can handle a greater 
mechanical load without rupturing.  Plaques that contain a considerable 
number of macrophages tend to be weaker due to the capability of the 
macrophages to degrade the extracellular matrix.  Plaques are thinner and 
have weaker mechanical properties at the shoulders of the lesion, so this is a 
common site for disruption of the fibrous cap. 
 
Just as many factors can cause plaque vulnerability, many factors are 
involved with plaque stability.  Stable plaques include those with thicker 
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fibrous caps and high collagen content, and also plaques that greatly stenose 
the arterial lumen.  It is important to note, however, that lesions which cause a 
great degree of stenosis may still be clinically relevant due to their ability to 
cause ischemia.  They are also exposed to shear stresses far greater than 
normal, so hemodynamic flow may cause cap rupture in this case.  Plaques 
which contain calcium deposits are sometimes thought to be more stable 
because they take some of the mechanical load off of the fibrous cap.  This, 
however, is still up for debate and is not yet proven. 
 
CLASSIFICATION SYSTEMS 
 
Many researchers have attempted to provide a classification system to draw 
correlations between plaque stability, cellular content and progression of the 
disease.  The American Heart Association, through the work of H. C. Stary et 
al., developed a classification system in 1995 based on disease progression.  
This system divided the disease into six different states, the first three of 
which were considered early and stable, and the last three of which were 
considered advanced and vulnerable.  The first three types, named type I, 
type II, and type III, described the disease progression from initiation, to fatty 
streaks and dots, and finally to the accumulation of a lipid core.  The types 
beyond type III are considered advanced lesions and clinically relevant. 
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Once the lesion has a considerable lipid core, it is considered a type IV 
lesion, which is the first of the advanced lesions.  This legion contains a large 
accumulation of foam cells, which make up an eccentric lipid core visible to 
the naked eye, but does not normally narrow the lumen.  It also has not yet 
developed a significant increase in smooth muscle cells or fibrous tissue.  As 
far as mechanical stability, this type of lesion may be prone to fissure 
because of the lack of a strong fibrous cap. 
 
A lesion is considered to be type V if it has a decent amount of other 
materials, such as fibrous tissue or calcium, but it may or may not have a lipid 
core.  A fibroatheroma (lipid core surrounded by a fibrous cap) is a type Va 
lesion.  This also includes multilayered fibroatheromas (multiple atheromas 
layered in the intima and fibrous caps in between them).  If the lesion contains 
calcific regions, it is termed type Vb.  A lesion with minimal lipid content that 
lacks a lipid core is a type Vc lesion.  It could be made up of either fibrous 
tissue or mineralized deposits. 
 
Lesions of types IV and V become type VI lesions when they develop 
disruptions such as a fissure, rupture, hematoma, or formation of a thrombus.  
Stary et al. refer to this type as a complicated lesion.  A disruption of the 
surface makes the lesion type Via; a hematoma or hemorrhage, type VIb; and 
formation of a thrombus, type VIc.  Any lesion can also contain more than one 
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of these features, making it a type VIab, VIac, VIbc, or VIabc.  The plaque 
ruptures of type VI lesions are what cause clinical events. 
 
 
Figure 3.  PLAQUE CLASSIFICATIONS  Cross sections of each type of lesion as 
described by Stary et al. 43 
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Cross sections of each type of lesion described by Stary et al. are shown in 
Figure 3.  This classification system has been used to classify atherosclerosis 
in many studies since its creation in 1995; however, recent developments in 
the understanding of the disease have led some researchers to develop 
different techniques for determining the clinical relevance of various disease 
states. 
 
In 2003, the American Heart Association published an article by Morteza 
Naghavi et al. that focused on plaque vulnerability rather that disease 
progression.  This system makes some sense since it is the vulnerable 
lesions that are the most clinically relevant.  Their system uses nomenclature 
to describe lesions, rather than lumping lesions into different classifications.  
A combination of major and minor risk factors is used to describe the risk of 
plaque rupture.  These risk factors be due to the physical properties of the 
lesion, and can also be due to the physiologic state of the patient (such as 
those prone to platelet coagulation and hypertension).  Figure 4 is used by 
the group to outline different types of vulnerable plaque based on the physical 
properties of the lesion.  It is the intent of this system to treat each physical 
property of the lesion as a separate risk factor that may or may not develop in 
a specific order.  This way, each lesion can be defined according to its exact 
physical elements, without implying how long the lesion has been present. 
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Figure 4.   TYPES OF VULNERABLE PLAQUE  Examples of different types of 
vulnerable plaque as described by Naghavi et al. 34 
 
 
Naghavi et al. also aimed to unify the somewhat subjective research 
language.  They thought that the adjectives used by researches to describe 
histology and plaque vulnerability could have different meanings, depending 
on who used them.  Their proposed definitions are as follows: 
 Culprit plaque:  A plaque that has caused a coronary occlusion and 
death. 
Vulnerable plaque:  A plaque including risk factors that make it 
succeptible to becoming a “culprit” plaque. 
Table 1 by Naghavi et al. describes many previously used terms to describe 
the sort of plaque disruption that caused a culprit plaque. 
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Table 1:  Terminology for Culprit Plaques 
 
 
Table 2.  Different terminology used to describe culprit plaques, as researched by 
Naghavi et al.  34 
 
 
After describing the difference between culprit and vulnerable plaque, 
Naghavi et al. outlined some risk factors for vulnerable plaque.  The major 
risk factors are shown in Table 2.  They include active inflammation, a thin 
fibrous cap with a large lipid core, surface disruption with superficial platelet 
aggregation, fissured or injured plaque, and severe stenosis.  A thin fibrous 
cap in this classification system has a width of 100 µm or less, and a large 
lipid core is one that makes up 40% or more of the lesion volume.  They 
consider severe stenosis as a major risk factor because shear stress on the 
plaque surface increases with the narrowing of the lumen. 
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Table 2: Risk Factors of Vulnerable Plaque 
 
   Major              Minor 
Active Inflammation Superficial calcified modules 
(close to fibrous cap) 
Thin fibrous cap (<100 µm) with large lipid 
core (>40% of plaque volume) 
Yellow color seen during 
angioplasty 
Surface disruption and superficial platelet 
aggregation 
Intraplaque hemorrhage 
Fissured or injured plaque Endothelial dysfunction 
Severe stenosis Positive (toward tunica media) 
remodeling 
 
Table 3.  Major and minor risk factors for vulnerable plaque determined by Naghavi et 
al. 
 
 
The minor risk factors outlined in the group’s work are also outlined in Table 
2.  They include: superficial calcified nondules, yellow color on angioscopy, 
intraplaque hemorrhage, endothelial dysfunction, and positive remodeling.  If 
calcium nodules are located near the cap instead of on the medial side of the 
lesion, they can protrude through the cap, causing rupture.  A yellow color on 
angioscopy can denote a large lipid core and thin fibrous cap, in which case it 
could be a major risk factor.  An intraplaque hemorrhage can disrupt the 
plaque stability.  Endothelial dysfunction is considered a minor risk factor due 
to the possibility of inflammation and the observed correlation to coronary 
disease and stroke.  Remodeling of the intima that preserves the lumen and 
instead expands the artery can be seen as a minor risk factor due to the 
correlation of clinical events with non stenosed arteries.  These minor risk 
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factors, while not a direct precursor to coronary events, have been observed 
in arteries undergoing coronary events, so they are worth noting in the 
prediction of plaque vulnerability. 
 
This method of describing atherosclerosis provides detailed communication 
between researchers.  It seems that in recent years, scholars in the field have 
started to shy away from the popular Stary et al. “type” classification system, 
and have instead defined lesions based on their individual properties.  For the 
purposes of this paper, individual traits will be used to describe various 
lesions.  
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CHAPTER TWO:  USING TECHNOLOGY TO DISCOVER PLAQUE 
VULNERABILITY 
 
The use of technology to diagnose high risk states of atherosclerosis is a 
growing field of research.  Currently, angiography and the diagnosis of patient 
risk factors are the only methods of predicting potentially fatal clinical events.  
Angiography comes with a great possibility of risk to the patient because of its 
invasive nature. One major drawback is that it only allows the physician to 
observe the endothelial lining of the lesion, which means he/she can not 
determine much other than the degree of stenosis.   
 
The identification of patient risk factors allows for correlation to plaque 
vulnerability, and may aide in the prediction of a clinical event, but it does not 
perfectly predict that possibility.  Many researchers are attempting to develop 
non-invasive techniques for the diagnosis of vulnerable disease states by 
finding correlations between medical images and mechanical stability.  
Images can be combined with previous knowledge about physical properties 
of lesions and vulnerability to predict more accurately the behavior of a 
specific lesion.  
 
Medical images, such as MRIs, provide entire cross sections of arteries with 
lesions.  They show great promise in distinguishing between the different 
materials of the plaque, and are already a widely used diagnostic tool.  Not 
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only is it a great non-invasive technique for looking at tissues inside the body, 
but it can also pick up on materials not visible to the naked eye.  The media 
used to scan can vary depending on the image type.  For instance, ultrasound 
and MR techniques use harmless sound and magnetic waves to determine 
the shape of the tissue of interest, while CT and fluoroscopy techniques use 
radiation.  The type of imaging used depends on the make-up and density of 
the tissue of interest.  In the vascular field, a few techniques are currently 
being researched to determine lesion composition.  These include ultrasound 
(US), magnetic resonance (MR) imaging, and optical coherence tomography 
(OCT). 
 
Research is being done to correctly correlate images with known mechanical 
properties for use in finite element analysis.  This may sound like 
straightforward research in theory, but the numerous combinations of lesion 
materials and mechanical properties makes data unification pretty difficult.  
The aim of this chapter is to explore current research in each of these areas, 
and consider how they are capable of fitting together. 
 
MECHANICAL ANALYSIS USING IVUS 
 
Intravascular ultrasound (IVUS) elastography can be used as a functional 
imaging technique, because it allows for both visualization of lesion 
components and compressive radial strain.  An example of an IVUS 
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elastogram is shown by Figure 5, which was produced in a study done by 
Radj A. Baldewsing et al.  The figure shows the elastograms with the 
corresponding histological images of the excised arteries used.  They 
compared this elastogram with a finite element analysis done on a geometry 
obtained from the ultrasound image.   
 
 
Figure 5.   IMAGES OF IVUS ELASTOGRAMS  Images of an artery cross section from 
the work of Baldewsing et al.  (a) IVUS image.  (b)  IVUS elastogram.  (c)-(e) histological 
images.  3 
 
Their results are shown in Figure 6.  While the IVUS elastogram is a good 
indicator of arterial strain, the group argues that a finite element analysis may 
be needed to verify that certain areas of strain are in fact due to lesion 
components.  They say that the strain in IVUS elastography may be altered 
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due to artery material properties, geometry, and placement of the IVUS 
catheter.  The lesion and arterial components were given linear elastic and 
incompressible material properties.  The justification for this is that the range 
of physiologic deformations is small enough for the system to be locally linear 
elastic. 
 
 
Figure 6.  IVUS STRESS/STRAIN ANALYSIS  Results of the stress/strain analysis by 
Baldewsing et al.  (a) optical image (b) IVUS elastogram (c) FEA analysis (d) diagram of 
Young's modulus used in the  
FEA. 3 
 
 
MECHANICAL ANALYSIS USING MR IMAGING 
 
Magnetic resonance imaging is perfect for looking at soft tissues in the body.  
It can have great resolution, and can be manipulated to further single out 
certain tissue characteristics, such as fat.  MR imaging has been used in 
research to help determine tissue composition of lesions.  Many studies have 
used real MR images to determine lesion geometries for finite element 
analysis. 
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Z. Yong Li et al. used this type of imaging for their finite element analysis of 
ruptured plaques.  They analyzed cross sectional MR images of excised 
arteries and ran a two dimensional stress analysis using ABACUS.  Five 
vulnerable plaques were used in this study, three that had not ruptured, and 
two that had.  The MR based geometries were obtained from MR 
segmentation software based on the image characteristics of each material.  
They also compared the MR based geometry with a histological based 
geometry for each cross section.  Figure 7 shows a comparison from their 
study.   
 
 
Figure 7.  FEA GEOMETRIES BASED ON MR IMAGES  Images of a specimen used for 
FEA in the work of Li et al.  (a) (b) (d) (e) MR images.  (c) histological image.  (d) 
geometry used for FEA based on MR images. 23 
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The final geometries contained three different plaque components: the artery 
wall, lipid pool, and fibrous cap.  The materials were given consistent 
properties throughout the study, so that the results could emphasize the effect 
of the geometry on plaque rupture.  An Ogden strain energy formulation was 
chosen for the material properties in their finite element analysis.  The 
purpose of this was to try to simulate the non-linear material properties of 
arteries and atherosclerotic lesions.  The results shown in their analysis can 
be seen in Figure 8.   The peak stress of the ruptured plaques are about 6.5 
MPa, and 1.5 MPa to 3.5 MPa for the ruptured but vulnerable plaques. 
 
 
Figure 8.  MAXIMUM STRESSES OF VULNERABLE PLAQUES  Results shown by Li et 
al. of the peak stress after finite element analysis of 5 excised arteries.  Specimins 1-3 
were unruptured, and specimens 4 and 5 were ruptured. 23 
 
This study showed similarities between the MR and histological based 
geometries, and showed that MR imaging could be promising to the field 
because it allows for computer aided geometries.  This method could greatly 
increase the accuracy and repeatability of geometry determination. 
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MECHANICAL ANALYSIS USING OCT 
 
Optical coherence tomography works in a similar manner as ultrasound, but it 
uses light waves as its medium.  OCT is a newer technology, and is 
promising because of its high resolution (10 µm X 25 µm).  The high 
resolution is a result of technology because it requires a light source that can 
emit a broad range of frequencies. 
 
Alexandra H. Chau et al. did a study where they compared the analysis of 
geometries obtained from OCT images with those obtained from histological 
images.  They used two types of lesions: one with a lipid pool and fibrous 
plaque surrounding it, and one with fibrous plaque surrounding a calcium 
deposit.  The determined geometries (with lipid pools) from each imaging 
method are shown in Figure 9 along with their stress and strain analysis.  
Their analysis was on a two dimensional cross section of an excised artery.  
Their analysis showed that OCT based geometries provide similar stress and 
strain distributions, but the peak stresses could appear much lower than the 
histological based geometries.  They attributed this inconsistency to the fact 
that the histological based image may have sharper edges and shoulders due 
to processing. 
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Figure 9.  ANALYSIS OF PLAQUE DEFORMATION  Comparison of geometry 
determination and finite element analysis done by Chau et al.  The left side is an OCT 
image set, and the right side is the corresponding histological image. 5 
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CHAPTER THREE:  THE IMPACT OF LIPID PERCENTAGE ON FIBROUS 
CAP STABILITY 
 
There is quite a bit of current research in the field of atherosclerosis.  Some 
researchers are doing physical experiments on excised arteries to determine 
the mechanical properties of each component of a lesion.  Others are creating 
both two and three dimensional finite element analyses based on these 
mechanical properties, and use geometries based on histological images of 
excised arteries.  Others still are attempting to use imaging techniques to 
determine mechanical properties, and comparing the finite element analyses 
of geometries based on imaging to those based on excised arteries. 
 
No research yet has focused on providing a method of standardizing the finite 
element analysis to draw correlations between different lesion compositions 
and geometries and mechanical stability.  Because each lesion is so different, 
it would be extremely helpful to create an analysis system where any lesion, 
regardless of its shape, size, or composition, could be analyzed quickly and 
accurately for plaque stability.  
 
This project uses finite element techniques to examine the stress 
concentrations between different plaque compositions.  The main focus is to 
determine the change in plaque stability as the ratio of lipid content to fibrous 
tissue content changes.  A two dimensional finite element analysis was done, 
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and the lipid and fibrous tissue content was varied linearly.  Each two 
dimensional drawing represented a cross section of a carotid artery, with a 
five millimeter diameter.  Since the purpose of this study was to look at the 
effects of lipid vs. fibrous tissue content, each cross section represented a 
single layered atheroma, with no presence of calcium.   
 
MATERIALS AND METHODS 
 
Each arterial cross section was analyzed using COMSOL Multiphysics two 
dimensional stress-strain analysis.  The artery was considered to be a closed 
system, and every component of the artery was given its own material 
properties.  The lumen was not considered part of the system because 
research showed that hemodynamic stresses are negligible.   
 
.An example of a typical cross section geometry can be seen in Figure 10. 
This shape was chosen due to a couple factors.  The cross section was to be 
asymmetrical in only one direction, in order to simplify the analysis and obtain 
continuity of the results.  A lesion shape was chosen based on typical lesion 
shapes shown in studies.  After a vague shape was chosen, it needed to be 
represented mathematically.  Many options exist to represent a typical lesion 
shape; however the chosen shape had to be able to range from 10%-90% 
lipid, and still be contained in the borders of the circular 5mm diameter artery.  
Although larger lesions tend to distort the outer diameter of the artery, a 
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circular shape was chosen throughout all cross sections to avoid any stress 
concentration gradients due to the artery shape.  The final shape of the 
atheromatous core was made by the area between two offset circles.  The 
diameter of the superficial circle was twice the size of the inner circle.  The 
cap thickness was the distance between the lumen and inner edge of the 
atheromatous core.  The lumen and outer edge of the core were equidistant 
from the artery wall, and the lesion was also centered in the other dimension. 
 
The materials were given linear elasticity, and the elastic modulus, E, for each 
is shown in Table 3.  The Poisson’s ratio for all materials was 0.4999.  These 
values were kept constant throughout each analysis as a control variable, and 
are the values used in work by Radj A. Baldewsing et al.  The percent 
stenosis was kept constant at 50%.  This was a realistic number for lesions of 
interest, without being so great as to cause extra shear stress on the lesion 
due to hemodynamic flow.  The percentage of the artery area that makes up 
the plaque was determined from this stenosis. The lipid and plaque 
percentages were calculated based on the entire lesion area.  The lipid 
percentage was ranged from 10% to 90%, and the cap thickness was varied 
from 65µm to 250 µm.  This is the range of cap thickness that is typically 
considered vulnerable.  The values chosen for thickness were 65µm, 100µm, 
200µm, and 250µm.  These values were chosen to represent the smallest 
realistic cap thickness and the largest vulnerable cap thickness.  The two 
values in between were chosen as references for values in between.  The 
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applied pressure on all analyses was 16 kPa, which is equivalent to about 
120 mmHg.  This pressure was applied to the lumen wall, and was chosen 
because it represents a systolic blood pressure on the higher end of the 
normal range for adults. 
 
Table 4.  Elastic Modulus of Artery and Lesion Components 
 
Material Artery Wall Lipid Pool Fibrous Tissue 
Elastic Modulus, E 16.8 kPa 50kPa 1250kPa 
 
 
The shape and material properties of the arterial wall were kept constant 
throughout all cross sections.  The shape of the artery wall was chosen to be 
circular, and the lesion was chosen to be off center.  This is in part due to the 
fact that most lesions are typically a bit eccentric, and are located on one side 
of the artery.  The distance between the lumen and arterial wall, and the lipid 
and arterial wall were chosen to be equidistant, to avoid any unsymmetrical 
stress concentrations due to a thin artery wall.  Since three separate tunics 
make up the arterial wall, they were averaged into one elastic modulus and 
thickness. 
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RESULTS 
 
Figure10 shows an example of a typical analysis.  Figures 11-14 show plots 
of the lipid percentage vs. peak stress on each analysis based on the fibrous 
cap thickness.  Each individual analysis can be seen in Appendix A.  The 
results show a linear increase in peak stress as the lipid pool grows.  The R2 
values are consistently close to 1.0, ranging from 0.927 to 0.976.  The peak 
stresses for forty to fifty percent range from 2E6 to 6E6 depending on the cap 
thickness.  This is higher than the finite element analyses done on geometries 
based on excised arteries, but this is due to the ideal nature of the 
geometries.  This limitation and the possibilities of overcoming it are 
explained later in this project. 
 33 
 
Figure 10.  FEA EXAMPLE USING COMSOL  Example of a finite element analysis using 
COMSOL Multiphysics. 
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Figure 11.  FEA RESULTS WITH A 65 µm FIBROUS CAP  Results of a finite element 
analysis of cross sections ranging from 10% lipid to 90% lipid with a 65 µm fibrous cap 
thickness. 
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Figure 12.  FEA RESULTS WITH A 100 µm FIBROUS CAP  Results of a finite element 
analysis of cross sections ranging from 10% lipid to 90% lipid with a 100 µm fibrous 
cap thickness. 
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200 µm Fibrous cap R2 = 0.9599
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Figure 13.  FEA RESULTS WITH A 200 µm FIBROUS CAP  Results of a finite element 
analysis of cross sections ranging from 10% lipid to 90% lipid with a 200 µm fibrous 
cap thickness. 
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Figure 14.  FEA RESULTS WITH A 250 µm FIBROUS CAP  Results of a finite element 
analysis of cross sections ranging from 10% lipid to 90% lipid with a 250 µm fibrous 
cap thickness. 
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DISCUSSION 
 
The peak stresses of this analysis are noticeably higher than typical finite 
element analyses done using histological geometries from cross sections of 
excised arteries.  This could possibly be due to the imperfect nature of 
physiologic geometries.   
 
Excised arteries typically have peak stresses located at the shoulders of the 
plaque, where curvature of the fibrous cap can be extremely sharp.  Also, the 
composition of both the lipid pool and the fibrous part of the plaque may not 
be completely uniform throughout; whereas the idealized model is uniform 
throughout.  The peak stresses can also be noticeably different from those 
obtained by experimentation of excised arteries due to all of the above 
reasons.  Another possibility for discrepancies between excised arteries and 
ideal models is the possibility of physical imperfections such as fissures.   
Natural lesions may also contain multiple atheromas and the presence of 
other materials such as calcium.  These factors would indeed affect the 
mechanical stability of the lesion, but are not portrayed in this project. 
 
Another physiologic feature of artery walls that is not portrayed in the finite 
element model is the ability of the wall to stretch to a wider diameter during 
pulsatile flow.  In the COMSOL analysis, the arteries are restricted to their 
5mm diameter, so the wall (and lesion) can be subjected to a higher 
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maximum stress than in physiologic conditions.  In the physiologic conditions, 
the minimum stress of the artery should be zero.  However, in the finite 
element analysis, there is a minimum stress that is greater than zero.  The 
difference between the peak stress and minimum stress represents the actual 
stress on the artery wall if the outer diameter was not constrained.  The “peak 
stress” in the results section depicts this value. 
 
It is important to note that the geometries chosen for this analysis are rather 
simple, and are not completely indicative of real lesion geometries.  For 
instance, in real lesions, the lipid pools are not shapes made up of offset 
circles with a perfectly uniform fibrous cap.  Instead, natural plaque buildup 
forms with sharp edges, especially near the shoulders of the lesion.  The cap 
thickness can also vary within the lesion.  This “roughness” creates many 
different stress concentrations throughout the fibrous cap where it could 
fissure or rupture at stresses well below those of the smooth sections.  Since 
the geometries of this project must use a method that is repeatable and 
consistent from one lipid pool size to the next, mathematically reproducible 
shapes are used.  The lipid pools of this project have smooth edges, and the 
fibrous cap is a consistent thickness throughout the lesion.  These smooth 
shapes obviously show stress similar to the smooth sections of real lesions, 
rather than the rough edges.  With further research, the natural stress 
concentrations could be incorporated into the finite element methods to show 
more realistic values.  However, accounting for these differences between 
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actual and ideal lesions is not easy, and requires a great deal of research and 
experimentation.   
 
A possible fix would be to compare the finite element analysis based on the 
geometries of actual lesions with those of the standardized geometries.  This 
difference could be plotted for each lipid volume percentage, to see if a 
correlation is present between the two graphs.  A finite element analysis could 
be done on each histological cross section based on the natural shape of the 
lesion.  Values for peak stress of lesions with similar material volumes (i.e. 
40% lipid and a minimum fibrous cap of 65 µm) could then be averaged to 
represent a large population.  This would help to achieve standardization.  
Also, the excised lesions would have to be examined to ensure the correct 
physical properties, such as cap thickness, material concentrations, and the 
elastic modulus of those materials.  Although it is very important to mimic 
lesion shape as closely as possible, this work would take a large amount of 
time and resources, so it is beyond the scope of this project. 
 
Another limitation of this project is the simplification of the material properties 
of plaque.  Realistically, each component of plaque probably has at least 
some non-linear elasticity.  However, there are many studies that show how 
the non-linear material properties may be negligible, so this study does the 
same.  The use of more physiologic material properties in finite element 
analyses is a large area of research that proves to be quite in depth in the 
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areas of mathematics and thermodynamics.  Thus, it is considered beyond 
the scope of this project. 
 
FUTURE IMPLICATIONS 
 
Although this project does not provide a direct solution to completely 
understanding plaque stability, it can be used to understand at least a part of 
it.  This project can be part of research to create a standardized model for 
plaque stability.  A standardized model could be an algorithm that takes input 
parameters specific to a certain lesion and outputs a finite element analysis.  
The use of imaging modalities certainly would play a big role, and may 
facilitate lesion analysis without even minimally invasive surgery. 
 
A foreseeable use of a standardized model in combination with medical 
imaging is the field of diagnostics.  Currently, many patients with 
atherosclerosis go undiagnosed until a major clinical event.  Others may know 
they have some sort of plaque buildup or risk factors, but may not know 
exactly how the disease will play out.  A standard diagnostic tool that predicts 
future behavior and current risk level would be a great tool for physicians and 
could prevent many injuries and even deaths due to atherosclerosis.  Even 
though a simple algorithm may not be achieved due to the complexity of the 
disease, a database that contains possible implications could be very useful 
in the prevention of disease progression.  This database could be a computer 
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program in which quantifiable parameters are entered and likely progressions 
and risk implications are outputted to the physician.  A chart could be used to 
identify risk based on non-quantifiable features, such as shape or 
nonsymmetrical lesions.  These methods could be of great use in the medical 
field, and help to achieve more efficient patient care. 
 
This sort of model would have a wide variety of applications in the clinical and 
industrial field.  For instance, non-invasive lesion analysis could allow 
cardiologists to determine plaque stability quicker and more accurately, 
resulting in safer and more efficient patient care.  In industry, a finite element 
model could be used for device testing before a physical artery model is even 
made.  The use of a computational model could provide easy reproducibility 
of these tests, thus allowing more analyses to be run.  If a large number of 
tests could be run in a short time, then a wide variety of lesions could be 
tested.  This is especially important because lesions vary so greatly in 
composition from person to person, and even between lesions themselves.    
 
Eventually, as all the limitations of this project are researched and overcome, 
a standardized model will come together and greatly improve the 
understanding of atherosclerosis. 
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APPENDIX 
 
This appendix displays the results of all COMSOL simulations used in this 
project. 
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The following are the finite element analyses for a fibrous cap thickness of 
200 µm with a lipid concentration ranging from 10% to 90% lipid. 
 
Fibrous Cap = 65µm  Atheroma = 10% 
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Fibrous Cap = 65µm  Atheroma = 20% 
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Fibrous Cap = 65µm  Atheroma = 30% 
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Fibrous Cap = 65µm  Atheroma = 40% 
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Fibrous Cap = 65µm  Atheroma = 50% 
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Fibrous Cap = 65µm  Atheroma = 60% 
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Fibrous Cap = 65µm  Atheroma = 70% 
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Fibrous Cap = 65µm  Atheroma = 80% 
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Fibrous Cap = 65µm  Atheroma = 90% 
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The following are the finite element analyses for a fibrous cap thickness of 
200 µm with a lipid concentration ranging from 10% to 90% lipid. 
 
Fibrous Cap = 100µm  Atheroma = 10% 
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Fibrous Cap = 100µm  Atheroma = 20% 
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Fibrous Cap = 100µm  Atheroma = 30% 
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Fibrous Cap = 100µm  Atheroma = 40% 
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Fibrous Cap = 100µm  Atheroma = 50% 
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Fibrous Cap = 100µm  Atheroma = 60% 
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Fibrous Cap = 100µm  Atheroma = 70% 
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Fibrous Cap = 100µm  Atheroma = 80% 
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Fibrous Cap = 100µm  Atheroma = 90% 
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The following are the finite element analyses for a fibrous cap thickness of 
200 µm with a lipid concentration ranging from 10% to 90% lipid. 
 
Fibrous Cap = 200µm  Atheroma = 10% 
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Fibrous Cap = 200µm  Atheroma = 20% 
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Fibrous Cap = 200µm  Atheroma = 30% 
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Fibrous Cap = 200µm  Atheroma = 40% 
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Fibrous Cap = 200µm  Atheroma = 50% 
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Fibrous Cap = 200µm  Atheroma = 60% 
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Fibrous Cap = 200µm  Atheroma = 70% 
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Fibrous Cap = 200µm  Atheroma = 80% 
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Fibrous Cap = 200µm  Atheroma = 90% 
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The following are the finite element analyses for a fibrous cap thickness of 
250 µm with a lipid concentration ranging from 10% to 90% lipid. 
 
Fibrous Cap = 200µm  Atheroma = 10% 
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Fibrous Cap = 200µm  Atheroma = 20% 
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Fibrous Cap = 200µm  Atheroma = 30% 
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Fibrous Cap = 200µm  Atheroma = 40% 
 
 
 
 73 
Fibrous Cap = 200µm  Atheroma = 50% 
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Fibrous Cap = 200µm  Atheroma = 60% 
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Fibrous Cap = 200µm  Atheroma = 70% 
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Fibrous Cap = 200µm  Atheroma = 80% 
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Fibrous Cap = 200µm  Atheroma = 90% 
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